Magstim LOGO.JPG
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
July 07, 2023 07:09 ET | Magstim EGI
WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...
Webinar Presenter
Developing New Treatments for Childhood Anxiety and OCD: Can Cognitive Control Help Kids Grow Out of Illness?
June 06, 2023 10:24 ET | Brain & Behavior Research Foundation
New York, June 06, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Developing New Treatments for Childhood Anxiety and OCD: Can Cognitive...
Magstim TMS OCD FDA Cleared photo
FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
January 18, 2023 13:05 ET | Magstim EGI
MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...
neurocare group AG Announces Publication Confirming the Importance of Sleep for Effectiveness of Combined rTMS and CBT for OCD
November 21, 2022 10:00 ET | neurocare group AG
MUNICH, Nov. 21, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
Virtual Reality for mental health
Chicago Behavior Center Utilizes Innovative Virtual Reality to Treat Obsessive-Compulsive Disorder and Anxiety Disorders
October 06, 2022 16:01 ET | Compass Health Center (compasshealthcenter.net)
CHICAGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Compass now offers Virtual Reality Care in its Adult Obsessive-Compulsive Disorder (OCD) and Complex Anxiety Programs across in-person locations and...
Webinar Presenter
Identification of Symptom-Specific Brain Circuit Abnormalities in Obsessive-Compulsive Disorder
September 01, 2022 08:00 ET | Brain & Behavior Research Foundation
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Identification of Symptom-Specific Brain Circuit Abnormalities in...
vaga-logo.png
VAGA Helps People Suffering with Poor Mental Health or Cognitive Decline Through Art Therapy
June 13, 2022 09:00 ET | Vaga
New York, June 13, 2022 (GLOBE NEWSWIRE) -- Mental health is a topic that has been under the spotlight in recent years, as people are realising that it is just as important as physical health and...
neurocare group AG Announces Recent Start of a Phase III Trial Examining the Cost-Effectiveness of TMS for Patients With Exposure Therapy-Resistant OCD
June 08, 2022 11:00 ET | neurocare group AG
MUNICH, June 08, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
Webinar Presenter
OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response - A Free Webinar from the Brain & Behavior Research Foundation
December 07, 2021 09:00 ET | Brain & Behavior Research Foundation
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “OCD: Using Genome Data to Predict Risk, Symptoms and Treatment Response”...
BransWay logo.jpg
BrainsWay’s Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session
October 06, 2020 09:00 ET | BrainsWay
CRESSKILL, N.J. and JERUSALEM, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...